SCHEMBL21997570

SCHEMBL21997570

N#CC1(CCNC(=O)O)CCC1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.32
P2RX7 Q99572 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11038280 0.75 ALDH1A2 (0.42) P2RX7
SCHEMBL31124660 0.75 LMNA (0.32) KDM1A
SCHEMBL25317589 0.72 KDM1A (0.37) KDM1AP2RX7
SCHEMBL2807409 0.70 HSD11B1 (0.41) KDM1A
SCHEMBL17446963 0.69 ALDH1A1 (0.35)
SCHEMBL21998137 0.68 USP2 (0.46)
SCHEMBL11606982 0.67 CYP2D6 (0.31)
SCHEMBL31124625 0.67 CYP1A2 (0.38)
SCHEMBL15140431 0.66 CYP2D6 (0.30)
SCHEMBL2805815 0.66 CYP2C19 (0.45) P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3886904-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2021-10-06 EP disclosed
WO-2020113233-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-06-04 WO disclosed